Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company working to unleash the human immune system to prevent, treat or cure cancer, autoimmune conditions and infectious diseases. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.
Domain
repertoire.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$189.0M
Founded
2014
Tech Stack (4 technologies)
Frequently Asked Questions
What technologies does Repertoire Immune Medicines use?+
Repertoire Immune Medicines uses 4 technologies including Cloudflare, HTTP/3, Open Graph.
What industry is Repertoire Immune Medicines in?+
Repertoire Immune Medicines operates in the Biotechnology industry.
Where is Repertoire Immune Medicines based?+
Repertoire Immune Medicines is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026